These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9711355)

  • 1. Effects of Ca2+ ions on survival, growth, and cell size in Serratia marcescens SMG40 exposed to mecillinam.
    Gratia JP
    Arch Physiol Biochem; 1998 Aug; 105(4):347-57. PubMed ID: 9711355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous zygogenesis (Z-mating) in mecillinam-rounded bacteria.
    Gratia JP
    Arch Microbiol; 2007 Dec; 188(6):565-74. PubMed ID: 17687545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spheroplast induction in clinical isolates of Serratia marcescens in the presence of Ca2+ or Mg2+.
    Tada Y; Yamaguchi J
    J Clin Microbiol; 1987 Nov; 25(11):2154-8. PubMed ID: 3320083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
    Gunkel AG; Hechler U; Martin HH
    J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergic post-antibiotic effect of mecillinam, in combination with other beta-lactam antibiotics in relation to morphology and initial killing.
    Hanberger H; Nilsson LE; Svensson E; Maller R
    J Antimicrob Chemother; 1991 Oct; 28(4):523-32. PubMed ID: 1761447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of cephalexin with mecillinam.
    Otsuki M
    J Antibiot (Tokyo); 1981 Jun; 34(6):739-52. PubMed ID: 6268594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combination of cefsulodin and mecillinam.
    Kondo M; Tsuchiya K
    J Antibiot (Tokyo); 1981 Jun; 34(6):727-38. PubMed ID: 6268593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activity of bacteriocins and cefotaxime against Serratia marcescens clinical isolate SMG40 and its pigmented variant.
    Gratia JP; Crenier L
    Zentralbl Bakteriol; 1992 Feb; 276(3):340-6. PubMed ID: 1576403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftazidime combined with mecillinam: serum bactericidal titres compared with in-vitro synergy against gram-negative bacilli.
    Van der Auwera P; Vandermies A; Lieppe S; Grenier P; Bourguignon AM; Ernst F
    J Antimicrob Chemother; 1988 Jun; 21(6):745-53. PubMed ID: 3045067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia.
    Weinstein RJ; Young LS; Hewitt WL
    J Lab Clin Med; 1975 Nov; 86(5):853-62. PubMed ID: 810533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of the cysteine regulon of Salmonella typhimurium in LB medium affects the response of cysB mutants to mecillinam.
    Antón DN
    Curr Microbiol; 2000 Jan; 40(1):72-7. PubMed ID: 10568808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of mecillinam against ESBL producers in vitro.
    Thomas K; Weinbren MJ; Warner M; Woodford N; Livermore D
    J Antimicrob Chemother; 2006 Feb; 57(2):367-8. PubMed ID: 16354745
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in 24-h time-kill experiments.
    Skarp KP; Shams A; Montelin H; Lagerbäck P; Tängdén T
    Int J Antimicrob Agents; 2019 Jan; 53(1):74-79. PubMed ID: 30236958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative synergistic activity of amikacin, gentamicin, netilmicin and azlocillin, mezlocillin, carbenicillin and ticarcillin against Serratia marcescens.
    Fu KP; Neu HC
    J Antibiot (Tokyo); 1978 Feb; 31(2):135-40. PubMed ID: 344298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphology of an Escherichia coli mutant with a temperature-dependent round cell shape.
    Iwaya M; Goldman R; Tipper DJ; Feingold B; Strominger JL
    J Bacteriol; 1978 Dec; 136(3):1143-58. PubMed ID: 363690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of osmolality on the response of Escherichia coli to mecillinam.
    Greenwood D
    Antimicrob Agents Chemother; 1976 Nov; 10(5):824-6. PubMed ID: 795371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined antimicrobial action of mecillinam and ampicillin].
    Khantimer EI
    Antibiotiki; 1983 Aug; 28(8):589-91. PubMed ID: 6314880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing frequency of mecillinam-resistant shigella isolates in urban Dhaka and rural Matlab, Bangladesh: a 6 year observation.
    Hossain MA; Rahman M; Ahmed QS; Malek MA; Sack RB; Albert MJ
    J Antimicrob Chemother; 1998 Jul; 42(1):99-102. PubMed ID: 9700536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ppGpp concentration, growth without PBP2 activity, and growth-rate control in Escherichia coli.
    Joseleau-Petit D; Thévenet D; D'Ari R
    Mol Microbiol; 1994 Sep; 13(5):911-7. PubMed ID: 7815948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of serum and blood on Enterobacteriaceae grown in the presence of subminimal inhibitory concentrations of ampicillin and mecillinam.
    Lorian V; Atkinson BA
    Rev Infect Dis; 1979; 1(5):797-806. PubMed ID: 232297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.